*Gyre Therapeutics Believes That Its Existing Cash Resources, Combined With Anticipated Cash Flow From Comml Ops, Will Be Sufficient to Fund Its Operating and Cap Requirements for the Next 12 Mos >GYRE

Dow Jones · 05/09 10:01

Please log in to view news